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Enzymology tends to focus on highly speciﬁc effects of substrates, allosteric modiﬁers, and products
occurring at low concentrations, because these are most informative about the enzyme’s catalytic
mechanism. We hypothesized that at relatively high in vivo concentrations, important molecular
monitors of the state of living cells, such as ATP, affect multiple enzymes of the former and that
these interactions have gone unnoticed in enzymology.
We test this hypothesis in terms of the effect that ATP, ADP, and AMP might have on the major
free-energy delivering pathway of the yeast Saccharomyces cerevisiae. Assaying cell-free extracts, we
collected a comprehensive set of quantitative kinetic data concerning the enzymes of the glycolytic
and the ethanol fermentation pathways. We determined systematically the extent to which the
enzyme activities depend on the concentrations of the adenine nucleotides. We found that the
effects of the adenine nucleotides on enzymes catalysing reactions in which they are not directly
involved as substrate or product, are substantial. This includes effects on the Michaelis–Menten con-
stants, adding new perspective on these, 100 years after their introduction.
 2013 Published by Elsevier B.V. on behalf of the Federation of European Biochemical Societies.1. Introduction systems [1–3]. In order to complement existing top-down and bot-Systems Biology is the science that aims to discover how biolog-
ical function emerges from the interactions of components of livingtom-up systems biology strategies, a ‘domino’ approach that starts
from both the edges and the nodes of the network has been devel-
oped [4]. To demonstrate the principles of the approach, we started
with ATP (and ADP and AMP) as the most-connected molecule [5]
and focused on the main pathways involved in ATP synthesis
(catabolism), in ATP consumption for growth (anabolism), and in
ATP consumption not coupled to growth (e.g. maintenance). We
expected the network around ATP to be limited to those enzyme
reactions that consume or produce ATP.
Although abundant experimental data are available onmany cel-
lular (sub) systems, including Saccharomyces cerevisiae and its gly-
colysis, combining these can often be near to impossible as each
data set stems from a different experimental setup. Hence, integra-
tion of experimental, computational, and theoretical approaches
within the ﬁeld of systems biology necessitates a standardization
in experimental conditions and procedures [6,7]. For yeast systems
biology this has led the yeast systems biology network to produce a
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sortium to produce a consensus genome-wide metabolic map [5,9].
However, standardization in itself is not enough. The standards
should provide data that represent the actual in vivo situation. For
enzyme kinetics assays, a medium has been developed that mimics
the cytosolic environment of S. cerevisiae [10]. The activities of yeast
glycolytic (and ethanol fermentation) enzymes as measured in the
assays optimized for the individual enzymes differed from their
activities in this in vivo medium. More surprisingly perhaps, some
enzyme activities under these in vivo-like conditions were signiﬁ-
cantly higher than the ones measured in the individually optimized
assays. The emphasis of the paper of Van Eunen and co-workerswas
on effects on the kcat of generic medium conditions such as ionic
strength, pH, and inorganic phosphate (‘buffer’) concentration.
Here we shall take the standardization effort one step further
and assess the effects of the concentrations of substrates and cofac-
tors on enzyme activities: the focus of this paper rests on the effect
of ATP, ADP, and AMP on the activity of the glycolytic enzymes. The
inhibitory or activatory effect of these nucleotides is often only
taken into account when they are substrates or products of a par-
ticular enzyme. A more general overall regulatory role of these
nucleotides is not yet part of the standard biochemical paradigm.
Four glycolytic enzymes have adenine nucleotides as cosub-
strates, but the others do not. For the former enzymes low-afﬁnity
effects of the adenine nucleotides in standard enzymology assays
must have been obscured by the stronger, more speciﬁc, effects.
Our hypothesis is therefore most pertinent for interactions of the
nucleotides with the latter enzymes. Molecular biochemistry
would expect these as speciﬁc allosteric interactions, which are
traditionally observed at submillimolar concentrations of the effec-
tors. For the yeast glycolytic enzymes, these additional allosteric
interactions are unknown. In the case of intracellular free ion con-
centrations, however, the effects occurred in the multiple millimo-
lar range [10], suggesting that much less afﬁne interactions,
usually unnoticed in molecular enzymology, might still be relevant
for the enzymes functioning in pathways in vivo. Therefore, to test
our hypothesis, we here examined whether in the millimolar con-
centration range, adenine nucleotides affected the activity of the
glycolytic enzymes. We use the standardised in vivo-like assay
medium, together with extracts from cells grown under standard-
ized growth conditions [8,10–11] to generate a comprehensive set
of kinetic data with regard to the effects of ATP, ADP, AMP on the
glycolytic enzymes in S. cerevisiae. We validate our hypothesis of
pleiotropic effects of the energy-state-monitoring metabolites on
the components of the glycolytic and ethanol-fermentation path-
way, both experimentally and in silico in the glycolysis model
developed by Teusink and co-workers [12].
2. Materials and methods
2.1. Strain and growth conditions
The haploid, prototrophic S. cerevisiae strain CEN.PK 113-7D
(MATa, MAL2-8c, SUC2, provided by P. Kötter, Frankfurt, Germany)
was used. For each continuous culture, a pre-culture was started
from a fresh glycerol stock (stored at 80 C); and grown in a ﬂask
on a rotary shaker at 30 C in the medium described below. The
glycerol stocks had been prepared by adding 30% glycerol (v/v)
to a stationary-phase culture started with a colony taken by the
provided plate and grown under the same conditions as the pre-
culture.
Aerobic glucose-limited chemostat cultivations were carried
out in 2 L fermenters (Applikon, Schiedam, the Netherlands), at
30 C, with a culture volume of 1 L, a stirring rate of 800 rpm, an
aeration rate of 0.50 L of air per minute, and a dilution rate of
0.1 h1. The cultures were fed a deﬁned mineral medium [13], with42 mM glucose as the growth-limiting nutrient. The volume of the
culture was kept constant by an efﬂuent pump, coupled to a pre-
set level sensor. The fermenters were thermostated with water
jackets. The extracellular pH was monitored and kept at 5.0 ± 0.1
through automatic drop-wise addition of a 2 M KOH solution. Oxy-
gen saturation was monitored with a dissolved-oxygen electrode
as well and found to be sufﬁcient for the cells to grow fully respir-
atorily. To avoid excessive foaming of the culture, 0.0025% (v/v)
anti-foaming agent (Sigma) was added to the medium. Cultures
were assumed to be at steady state after at least ﬁve volume
changes and when the culture dry weight and the speciﬁc oxygen
consumption rate and carbon dioxide production rate changed less
than 2% upon a further full volume change.
2.2. Steady-state measurements
Culture dry weights were determined by ﬁltering, washing, and
drying culture samples, essentially as described in [14]. However,
here ﬁlters were dried overnight in a 60 C incubator. The oxygen
consumption and carbon dioxide production rates were deter-
mined by analysing the efﬂuent gas from the fermenters with a
gas analyser.
2.3. Preparation of cell-free extracts
Once the culture reached steady state, cells were harvested and
prepared for storage by centrifugation (3850g for 5 min at 4 C),
washed twice with 10 mM potassium phosphate buffer (pH 7.5)
containing 2 mM EDTA, concentrated 20-fold by centrifugation,
and stored as 1.0 ml aliquots at 20 C. Just prior to use, the 1 ml
samples were thawed on ice, washed twice by centrifugation
(3850g for 5 min at 4 C) and resuspended in 1.0 ml of 100 mM
potassium phosphate buffer (pH 7.5) containing 2.0 mM MgCl2
and 1.0 mM dithiothreitol (DTT). Cell free extracts were made by
disrupting the cells with acid-washed glass beads (425–600 lm)
in a FastPrep (Qbiogene) machine, by eight bursts of 10 s each at
a speed of 6.0 m s1. Samples were cooled on ice for 60 s in be-
tween bursts. Cell debris was removed from the extracts by centri-
fugation (3850g for 15 min at 4 C).
2.4. Measurement of enzymatic rates – general procedure
Reaction rates of enzymes were measured by monitoring the
reduction of NAD(P)+ or oxidation of NAD(P)H at 340 nm. The
activity of phosphoglycerate mutase (PGM) and enolase (ENO)
was measured by monitoring the production of phosphoenolpyr-
uvate (PEP) at 240 nm. As detailed below, to some activity assays,
additional enzymes and substrates had to be added to couple the
reaction to one that could be monitored.
In order to mimic the in vivo situation as much as possible, the
standardised in vivo-like assay medium as described in [10] was
used. This medium (pH 6.8) contained 300 mM potassium,
245 mM glutamate, 50 mM phosphate, 20 mM sodium, an esti-
mated 2 mM ‘‘free’’ magnesium (not bound to adenosine nucleo-
tides, NADP+ or TPP), 2.5–10 mM sulphate (depending on total
magnesium addition) and 0.5 mM calcium. All substrate, co-fac-
tors, and coupling enzyme concentrations, including NADH etc.,
were checked to be sufﬁcient and, if needed, altered compared to
previously described assay concentrations, as described below. To
determine the effect of ATP, ADP, and AMP on the enzyme reaction
rates, these compounds were added to the assay mixture in a series
of concentrations up to 10 mM (0.1, 0.5, 1–3, 5, and 10 mM, respec-
tively) together with the same concentration of magnesium sul-
phate. Other additions to the assay varied with the individual
assays (see below). In this series of assays, the enzyme substrates
were varied individually at concentrations around their original
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out to be inhibited by the adenosine nucleotides, we double-
checked these enzyme concentrations to be sufﬁcient in the assays
in which additional adenosine nucleotides were added. For each
assay, cell-free extracts were diluted such that three or two dilu-
tions fell in the linear range of the assay.
The assays were carried out in a Spectramax plate reader
(Molecular Devices) at 30 C, using 96-wells plates with a ﬂat bot-
tom (Greiner 655101/655191 for the assays at 340 nm and Greiner
UV-Star for the ones at 240 nm). The standard assay volume was
300 ll, including 5.0 ll sample and 30 ll start reagent. Under the
conditions used here the ‘extinction coefﬁcient’ of NADH for a vol-
ume of 300 ll was determined to be 4.54 mM1 by measuring the
absorption at a series of NADH concentrations in a ﬁnal volume of
300 ll. Please note that this value is for a ﬁxed volume and hence is
a combination of the actual extinction coefﬁcient and the pathTable 1
Concentrations of substrates, co-factors and coupling enzymes used in the assays of
the glycolytic enzymes and the enzymes of the ethanol fermentation pathway in cell-
free extracts of S. cerevisiae described here ([new]) compared to the ‘‘traditional’’ ones
set up for maximal activity (see text) ([old]). The substrate concentrations given here
are the ones suggested for use in assays determining maximum enzymatic rates. To
determine the effects of the adenine nucleotides, substrate concentrations were
varied. Changes are marked in bold.
Enzyme Component [New] [Old]
HXK Glc 10 mM 10 mM
ATP 3 mM 1 mM
NADP+ 1 mM 1 mM
G6PDH 1.8 U ml1 1.8 U ml1
PGI G6P 25 mM 5 mM
ATP 1 mM 1 mM
NADH 0.15 mM 0.15 mM
PFK 1 U ml1 1 U ml1
ALD 0.45 U ml1 0.45 U ml1
TPI 1.8 U ml1 1.8 U ml1
G3PDH 0.6 U ml1 0.6 U ml1
PFK F6P 2 mM 0.25 mM
ATP 1 mM 0.5 mM
AMP 2 mM –
F26BP – 0.1 mM
NADH 0.15 mM 0.15 mM
ALD 0.45 U ml1 0.45 U ml1
TPI 1.8 U ml1 1.8 U ml1
G3PDH 0.6 U ml1 0.6 U ml1
ALD F16BP 20 mM 2 mM
NADH 0.15 mM 0.15 mM
TPI 1.8 U ml1 1.8 U ml1
G3PDH 0.6 U ml1 0.6 U ml1
TPI GAP 24 mM 6 mM
NADH 0.15 mM 0.15 mM
G3PDH 8.5 U ml1 8.5 U ml1
GAPDH GAP 4 mM 6 mM
NAD+ 5 mM 1 mM
ADP 0.5 mM 10 mM
PGK 22.5 U ml1 22.5 U ml1
PGK (reverse) 3PGA 25 mM 25 mM
ATP 2 mM 2 mM
NADH 0.15 mM 0.15 mM
GAPDH 8 U ml1 8 U ml1
PGM 3PGA 10 mM 5 mM
23BPGA 1 mM 1.25 mM
ENO 2 U ml1 1 U ml1
ENO 2PGA 3 mM 1 mM
PYK PEP 2 mM 2 mM
ADP 5 mM 10 mM
NADH 0.15 mM 0.15 mM
F16BP 1 mM 1 mM
LDH 13.8 U ml1 13.8 U ml1
PDC NADH 0.15 mM 0.15 mM
TPP 20 mM 20 mM
Pyr 50 mM 50 mM
ADH NAD+ 2 mM 1 mM
EtOH 1 M 0.1 Mlength. Determining the coefﬁcient for a ﬁxed volume eliminates
the large effect the meniscus might have on the path length in such
small volumes. For the assays based on the monitoring of PEP pro-
duction at 240 nm, the assay volume was reduced to 75 ll and the
maximum concentration of ATP/ADP/AMP to 5 mM, since the
absorption of these nucleotides at 240 nm rendered a too high
background signal otherwise, impairing the linearity of the assay.
The ‘extinction coefﬁcient’ of PEP for a volume of 75 ll was
0.554 mM1 (again, this value is a combination of the actual
extinction coefﬁcient and the path length). During the assay, ﬁrst
a base line was measured with only the sample and reagent pres-
ent. Then the machine was paused and the start reagent added
quickly. Absorbance was measured at 10 s intervals. All determina-
tions were done in triplicate using cell extracts from three different
cultures.
All enzyme activities were calculated as micromoles of sub-
strate converted per minute per milligram of extracted protein
(U (mg protein)1). Total extracted protein was determined with
a bicinchoninic acid kit (BCA Protein Assay Kit, Pierce, Thermo
Fisher Scientiﬁc) with bovine serum albumin (BSA, 2 g L1 stock
solution, Pierce) as standard. Since the DTT present in the extracts
inﬂuences the assay, it was added to the standards as well (1 mM).
2.5. Measurement of enzymatic rates – individual enzymes
The substrates, co-factors, and enzymes for coupled reactions
are given in Table 1. The ﬁnal column gives the concentrations
used in previous assays [10,15].
The activator of phosphofructokinase (PFK), fructose 2,6-bis-
phosphate (F26BP), was not commercially available anymore, thus
AMP was used (and checked) as an activator instead [16]. ADP is an
inhibitor of glyceraldehyde-3-phosphate dehydrogenase (EC
1.2.1.12) (GAPDH), but was needed for the coupling reaction.
Hence it was used anyway, but at a far lower concentration than
previously in [10,15]. Monitoring the production of PEP when mea-
suring the activity of PGM and ENO obviated the coupled reaction
of pyruvate kinase (EC 2.7.1.40) (PYK) which has ADP as a
substrate.
2.6. Calculations
Calculation of the kinetic parameters and determination of the
type of inhibition from the experimental data was done according
to the methods described in [17], using Hanes plots, Dixon plots
and plots suggested by Cornish-Bowden in Section 5.3 of the book.
2.7. Mathematical modelling
Model calculations were done in COPASI [18]. The glycolysis
model of Teusing and co-workers [12] was used as the basis of
the model used here. The inhibition of hexokinase by trehalose
6-phosphate and activation of pyruvate kinase by fructose 1,6-bis-
phosphate (F16BP) were introduced according to [19]. The ﬂuxes to
acetate, glycogen, succinate, and trehalose were set to be simple
mass action rates, as was the ATPase rate accounting for ATP util-
isation (cf. the original model [12]).
All experimental data was converted to units related to the
intracellular volume (mM for concentrations and mMmin1 for
rates) by assuming a cytosolic volume of 3.75 ml (mg cell pro-
tein)1 [20]. The values of the kinetic parameters determined here
were introduced in the model. Other parameters were kept the
same, with the exception of the (arbitrary) value of the kinetic
constant of the succinate ﬂux, which was set at 0.5 mM to preserve
a balanced system. The various inhibitory and activatory effects of
the presence of ATP, ADP, and AMP reported here were introduced
in the rate equations as speciﬁed in [17]. More speciﬁcally, for
Table 3
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and uncompetitive inhibition), the rate equation was divided by
the factor 1 + phi with phi = [ATP]/KIUATP + [ADP]/KIUADP + [AMP]/
KIUAMP and KIU the inhibition constant of uncompetitive component
of the inhibition by the particular nucleotide (if applicable). In the
case of uncompetitive or mixed inhibition, the KM of the substrate
was divided by the factor 1 + phi, while in the case of competitive
or mixed inhibition the KM was multiplied with a similar factor
1 + phi, but now including the inhibition constant of the competi-
tive component of the inhibition, instead of the uncompetitive
one. In keeping with the second law of thermodynamics, the KM
of the corresponding product was divided or multiplied by the
same factor as well. The experimentally observed activatory effects
of the nucleotides were introduced by multiplying the rate
equations by a factor 1 + n[ATP]/(KA-ATP + [ATP]) + n[ADP]/(KA-
ADP + [ADP]) + n[AMP]/(KA-AMP + [AMP]) with n = 2 for the nucleo-
tides involved.
3. Results
3.1. Determination of the maximum rates (Vmax) of the glycolytic
enzymes
First of all, we determined what the maximum rates (Vmax) of
the glycolytic enzymes in the cell-free extracts were when the pre-
viously established in-vivo-like assay medium was used [10]. By
deﬁnition, such a Vmax value only represents the maximum reac-
tion rate of an enzyme, measured in the presence of substrates in
saturating concentrations and the complete absence of products.
So-called optimal conditions for each enzyme used traditionally
[15], do not always give the highest maximum rate [10]. Hence,
to ensure that the concentrations of the individual substrates
(including coenzymes such as NADH), co-factors, and coupling en-
zymes were saturating, we ﬁrst varied these concentrations, both
below and above the ones prescribed by the assays set up for max-
imal activity [15], until we found saturating concentrations. To ex-
clude the effect of product inhibition, we only looked at initial
reaction rates. Since we used cell-free extracts for our assays and
not puriﬁed, reconstituted single enzymes, the rates given here
are for the pool of isoenzymes present in the extracts.
Surprisingly, we found that several substrate concentrations as
used in the ‘traditional’ assays set up for maximal activity (Table 1)
were not saturating; substrate concentration had to be increased
for the measured rates to become independent of these concentra-
tions and to thus establish the maximum enzyme activity under
the in vivo-like conditions used here (Table 2). These increasedTable 2
VMAX values (mean and their S.E.M.) for the glycolytic enzymes and the enzymes of
the ethanol fermentation pathway in cell-free extracts of S. cerevisiae as measured in
the in-vivo-like assay medium with the new set of saturating substrate, co-factor, and
coupling enzyme concentrations. Three series of independent measurements of a
relevant series of substrate, co-factor, or coupling enzyme concentrations were
carried out in extracts of three separate cultures each.
Enzyme VMAX (mmol min1 (g protein)1)
HXK 1.45 ± 0.086
PGI 1.95 ± 0.18
PFK 1.17 ± 0.10
ALD 3.90 ± 0.049
TPI 64.0 ± 6.4
GAPDH 5.74 ± 4.8
PGK (reverse rate) 12.1 ± 0.74
PGM 31.1 ± 5.1
ENO 5.90 ± 0.67
PYK 6.12 ± 0.45
PDC 1.37 ± 0.12
ADH (reverse rate) 21.1 ± 2.7concentrations amounted to up to ten times the original ones. In
addition, we observed that GAPDH is inhibited by ADP, a substrate
for the coupled reaction driven by 3-phosphoglycerate kinase (EC
2.7.2.3) (PGK) and needed to have the reaction remove the product
of GAPDH. Lowering the ADP concentration resulted in a signiﬁcant
increase in the rate of GAPDH. The concentration of the substrate
glyceraldehyde 3-phosphate (GAP) could be lowered and still be
saturating. A practical problem we encountered was the lack of
available (pure) fructose 2,6-bisphosphate, an activator of PFK
typically used in the PFK activity assay. We conﬁrmed that the
absence of any activator resulted in an extremely low, almost
undetectable enzyme activity, even at very high substrate concen-
trations (data not shown). Therefore, we used AMP as an activator
instead [16], which gave a physiologically relevant rate that would
support the glycolytic ﬂux under the growth conditions used here.
3.2. Determination of Michaelis constants (KM) of enzyme vis-à-vis
their substrates
Next, we determined the afﬁnity of the substrates for their en-
zymes. For most of the enzymes, we assumed Michaelis–Menten-
type kinetics as given in [12,17]. For PFK a two-substrate Monod,
Wyman, Changeux model for allosteric enzymes was used (see
for a description [12]).
To determine the Michaelis constants (KM) of the individual
substrates for the enzymes, the enzyme rates at various substrate
concentrations were measured and the KM calculated [17]. The
resulting values are given in Table 3. None of the results stand
out and – as discussed above – comparison with other datasets will
be hard, since the experimental conditions were different.
3.3. Determination of inhibition or activation of enzyme activities by
ATP, ADP, and AMP
In order to determine systematically whether, as in the hypoth-
esis we meant to test, ATP, ADP, and AMP affected enzymatic rates
also of reactions in which they were not involved as substrates or
products, the adenine nucleotideswere added to the assaymixtures
at concentrations ranging from 0 to 10 mM. We determined the
type of inhibition or activation (if present), by varying the concen-
trations of the substrates other than the nucleotides individually in
a range relevant for that particular substrate (as described in [17])
and the implications of our ﬁndings are shown in Table 4. Since ATP,
ADP, or AMP are typically available as sodium phosphate salts, weSubstrate afﬁnities of the glycolytic enzymes and of the enzymes of the ethanol
fermentation pathway in cell-free extracts of S. cerevisiae as measured in the in-vivo-
like assay medium with the new set of saturating substrate, co-factor, and coupling
enzyme concentrations. The afﬁnities are given as mean KM values with their S.E.M.,
n = 9.
Enzyme KM (mM)
HXK Glc 0.10 ± 0.012
ATP 0.37 ± 0.025
PGI G6P 1.8 ± 0.16
PFK See text
ALD F16BP 8.5 ± 0.91
TPI GAP 4.2 ± 0.68
GAPDH GAP 0.45 ± 0.060
PGK 3PGA 1.3 ± 0.089
ATP 0.31 ± 0.065
PGM 3PGA 5.1 ± 0.91
23BPGA 0.10 ± 0.018
ENO 2PGA 0.21 ± 0.036
PYK PEP 0.36 ± 0.20
ADP 1.2 ± 0.092
PDC Pyr 15.2 ± 2.1
ADH EtOH 233 ± 35
Table 4
Kinetic constants and their S.E.M. with regards to the effect of ATP, ADP, and AMP on the activities of the glycolytic enzymes and the enzymes of the ethanol fermentation pathway in cell-free extracts of S. cerevisiae as measured in the in-
vivo-like assay mediumwith the new set of saturating substrate, co-factor, and coupling enzyme concentrations. The effects are listed as seen when individual substrates are varied. In case of inhibition, the inhibition type is given as well.
‘‘None’’ means no effect of the nucleotide on the enzyme activity was seen in the concentration range used here. KIU and KIC denote the constants for uncompetitive and competitive components of the inhibition, resp. ((⁄) activity of ALD is
0 in the presence of 10 mM ATP; (⁄⁄) maximum at 3 mM; (⁄⁄⁄) activity of pyruvate decarboxylase (EC 4.1.1.1) (PDC) was undetectable in the presence of 10 mM AMP.)
Enzyme Varied substrate Kinetic constants (mM) Inhibition type
KIU or KA KIC
HXK Glc ATP 12 ± 0.18 – Uncompetitive
ADP 7.2 ± 1.1 – Uncompetitive
AMP 27 ± 3.6 – Uncompetitive
ATP ATP – – –
ADP 7.9 ± 1.1 5.4 ± 1.2 Mixed
AMP 5.5 ± 0.79 Competitive
PGI G6P ATP 3.9 ± 0.47 3.2 ± 0.67 Mixed
ADP 18 ± 2.1 4.2 ± 0.48 Mixed
AMP 14 ± 2.2 3.7 ± 0.49 Mixed
PFK See text See text
ALD F16BP ATP 1.1 ± 0.14 Non-competitive (⁄)
ADP – None
AMP 9.4 ± 1.1 Uncompetitive
TPI GAP ATP 12 ± 1.8 8.4 ± 1.7 Mixed
ADP 19 ± 3.1 15 ± 2.0 Mixed
AMP 22 ± 3.0 8.5 ± 2.3 Mixed
GAPDH GAP ATP 5.9 ± 0.57 – Uncompetitive
ADP 11 ± 1.5 – Uncompetitive
AMP 12 ± 1.8 – Uncompetitive
PGK 3PGA ATP 16 ± 2.6 – Uncompetitive
ADP 1.6 ± 0.28 – Non-competitive
AMP 19 ± 2.7 – Uncompetitive
ATP ATP – – –
ADP – 3.3 ± 0.46 Competitive
AMP – 3.2 ± 0.41 Competitive
PGM 3PGA ATP – – None
ADP 10 ± 1.3 – Activation
AMP – – None
23BPGA ATP – – None
ADP 7.8 ± 1.0 – Activation
AMP – – None
ENO 2PGA ATP – 3.2 ± 1.2 Competitive
ADP 2.1 ± 0.45 – Activation (⁄⁄)
AMP 4.3 ± 0.80 – Activation
PYK PEP ATP – – None
ADP – – None
AMP – – None
ADP ATP – – None
ADP – – –
AMP – – None
PDC Pyr ATP 13 ± 2.4 – Activation
ADP 21 ± 3.1 – Activation
AMP 29 ± 3.7 6.4 ± 1.3 Mixed (⁄⁄⁄)
ADH EtOH ATP 5.9 ± 1.0 – Uncompetitive
ADP 17 ± 2.1 – Uncompetitive
AMP 19 ± 2.5 – Uncompetitive
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Table 5
Steady state values of (A) metabolite concentrations and (B) enzymatic rates of
glycolysis and the fermentation pathway for the two versions of the model (base
Model 1 with no adenine nucleotide effects other than given in the model by Teusink
and co-workers and Model 2 with inhibitions and activations by adenine nucleotides
reported here added), as well as experimentally determined values from [25].
Model 1 Model 2 Experiment
(A) Rates (mM min1)
vGLT 53 24
vHXK 58 29 94 ± 4
vPGI–vALD 57 28 82 ± 3
vGAPDH–vPYK 103 53 147 ± 4
vPDC 98 51
vADH 98 51
vGlycerol 12 4.0
(B) Metabolites (mM)
GLCi 4.6 10
G6P 0.65 0.41 3.8 ± 0.1
F6P 0.10 0.032 0.74 ± 0.01
F16BP 35 4.5 12 ± 1
DHAP + GAP 7.2 2.2
BPG 1.1E-04 4.8E-05
3PGA 0.19 0.061 0.78 ± 0.02 (2PGA + 3PGA)
2PGA 0.022 0.0069
PEP 0.036 0.022 0.1 ± 0.01
PYR 4.6 1.5 2.8 ± 0.6
ACALD 0.17 0.25
ATP 2.3 1.2
ADP 2.6 2.6
AMP 1.4 2.5
NAD 1.6 1.8
NADH 0.024 0.017
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well and found them to be negligible for all enzymes. The same was
the case for magnesium sulphate (data not shown).
The results show that, with the exception of PYK, the activities
of all enzymes were indeed affected by the presence of ATP, ADP, or
AMP, also when they did not act as a substrate for the enzyme
(Table 4). Some effects were small, though. In general, the effect
of an adenine nucleotide as a substrate was (competitively) inhib-
ited by the others. In addition, some general, mixed-type inhibition
was seen with values for the inhibition constants (KIU and KIC) well
above 10 mM. An example is triosephosphate isomerase (EC
5.3.1.1) (TPI), of which all three inhibition constants were above
10 mM. Since the intracellular ATP, ADP, and AMP concentrations
tend to be below 10 mM [21–23], such high inhibitory constants
preclude large effects on enzyme activity.
However, some results stood out. The measurement of hexoki-
nase (EC 2.7.1.1) (HXK) activities revealed substrate inhibition by
ATP. In addition, even though the adenosine nucleotides are not
substrates of the enzyme, fructose 1,6-bisphosphate aldolase (EC
4.1.2.13) (ALD) was severely inhibited by ATP. A KI (non-competi-
tive) of only 1.1 mM was calculated, and at an ATP concentration
of 10 mM, no ALD activity could be detected. Phosphoglucose isom-
erase (EC 5.3.1.9) (PGI) activity was also severely inhibited by ATP.
ADP acted as an activator of PGM and ENO and AMP as one of ENO.
The kinetics of PFK are rather complex (see for a discussion
[12]). Within the range of substrate concentrations used here
(0.5–5 mM ATP and 0.5–5 mM fructose 6-phosphate (F6P)), no
inhibitory effect of any of the three nucleotides was seen. At an
AMP concentration of 0.5 mM, already full activity was found,
while an (activating) effect of ADP was only detected when AMP
was absent (60% of full activity at 2 mM).
3.4. In silico determination of the potential physiological relevance
The low-afﬁnity effects of adenine nucleotides on the rates of
glycolytic enzymes we observed should be relevant for the
relationships between the rates and the product/substrate concen-trations of the individual enzymes. However, this does not prove
that the effects would also be important for the physiological func-
tion of these enzymes in vivo, which is to produce the glycolytic
ﬂux resulting in glucose consumption and free-energy transduc-
tion, and perhaps to establish robust steady state concentrations
of glycolytic metabolites and of the adenine nucleotides them-
selves. For one, effects on enzymes without ﬂux control should
not be important for pathway ﬂux [24]. In addition, effects of ade-
nine nucleotides on multiple enzymes might cancel each other
when pathway ﬂux or metabolite concentrations are involved.
In order to examine the effects of the inhibition and activation
of the glycolytic and fermentation enzymes by the adenine nucle-
otides might have on the ﬂuxes of the system, we employed a
kinetic model of the glycolytic pathway. We used the well-estab-
lished model of Teusink and co-workers [12] as a starting point,
but made a few updates as described in Section 2. We introduced
the KM and Vmax values determined here, as well as the inhibitions
and activations by ATP, ADP, and AMP (see Section 2for the modi-
ﬁcations of the rate equations) and compared the results of the
model with the additional inhibitory and activatory effects of the
nucleotides present, to the one without these effects.
As shown in Table 5, the effects were substantial; in the version
of the model where the inhibitory and activatory effects have been
introduced, the ﬂuxes are only about half of the ﬂuxes in the model
without these activatory and inhibitory effects. The ATP concentra-
tion, together with most intracellular metabolites has dropped
considerably (Table 5); the ATP/ADP ratio decreased from approx-
imately 1 to 0.5. Clearly, the effects on pathway ﬂux and metabo-
lite concentrations of the adenine nucleotide inhibitions and
activations of the enzymatic rates should be expected to be sub-
stantial in the context of what we know about the pathway, which
is represented by the model.
4. Discussion
From a scientiﬁc point of view, standardisation is important.
From a physiology point of view however, standardisation is
important but not enough. Measurements need to be done under
physiologically relevant conditions. When Van Eunen and
co-workers [10] developed an assay medium that mimics in vivo
conditions for the cytosolic enzymes of S. cerevisiae they compared
enzyme activities measured under these in vivo conditions to those
measured in established assays under so-called ‘optimal’ condi-
tions for each individual enzyme and found major differences.
These authors only considered the effect of changes in the assay
medium; the concentrations of substrates, effectors, and coupling
enzymes remained unchanged. Here, we have also examined the
substrate concentrations forthe enzymes to reach their maximum
rates under this in vivo-like assay condition (Table 1) and found
that the Vmax values were higher than Van Eunen and co-workers
[10] found. The implication of applying in vivo-like conditions is
even greater than they may have realised.
In addition to determining the maximal rates of the enzymes,
we determined the afﬁnity coefﬁcients (Michaelis–Menten con-
stants; KM) of the various substrates for their enzymes, which is
what Van Eunen and co-workers [10] did not do. In light of the
on-going discussion on the need of standardisation, it should not
come as a surprise that we found it hard to compare this data sub-
set to previous data. For instance, in the case of hexokinase,
reportedKM values for the substrates glucose and ATP in a series
of publications range from 0.1 to 0.24 mM and from 0.063 to
2.9 mM, respectively [12,26–29]. This example suggests that not
using standardised, in vivo-like assay conditions not only leads to
kcat values unrepresentative for the in vivo functioning of the
enzymes, but also to unrepresentative KM values. Where kcat values
pertain to the maximum capacity of metabolic functions, the
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also for determining the in vivo concentrations of the metabolites
in the pathways. In turn – and more so than the ﬂuxes – these con-
centrations are important for the cross-regulation of and by other
pathways, for cell signalling, and for gene expression.
The ﬁndings of this paper suggest a new standard experimental
design for the characterization of enzymes. One should not mea-
sure an enzyme’s properties in fairly indeterminate conditions
such as deﬁned by ionic strength, pH, and buffer conditions.
Rather, one should also determine the low afﬁnity effects of many
functional components of the intracellular milieu. In addition,
medium effects should not only be measured for kcat, but also for
Michaelis–Menten constants. Our experimental conditions were
still a bit in limbo; the advice would be to measure effects both un-
der conditions where substrates are well above KM values (for ef-
fects on kcat) and under conditions where they are below/around
KM values (for effects onKM).
Most importantly perhaps, we have provided a comprehensive
set of quantitative data on the inhibitory and/or activatory effect
of the adenosine nucleotides ATP, ADP, and AMP on the individual
glycolytic enzymes. Besides giving general insight into the regula-
tory role of the nucleotides on the glycolytic rate, this set shows
that their effect on enzymes in the reactions of which they are
not directly involved, can be substantial and should hence not be
disregarded. An example is the strong inhibition of fructose 1,6-
bisphosphate aldolase by ATP.
That this is important for pathway function, is illustrated fur-
ther by our in silico modelling results; glycolytic ﬂuxes are strongly
affected when introducing these inhibitory and activatory effects.
We initiated this study on the basis of the hypothesis that
molecular monitors of important aspects of the cell’sstate may reg-
ulate cell function highly pleiotropically, i.e., by working on virtu-
ally all enzymes. We proposed that this regulation could well be
due to low-afﬁnity interactions with many enzymes for which
these monitors are neither a substrate nor a product. In this paper
we have validated this hypothesis for molecular monitors of per-
haps the most important aspect of the cell’s state, its Gibbs free en-
ergy potential. Indeed our hypothesis was validated for this case;
ATP, ADP, and AMP, affect the activity of most enzymes of the ma-
jor catabolic pathway of yeast and most often not through sub-
strate or product action.
The concentrations at which these energy monitors exercise
their pleiotropic effects are typically much higher than their KM
values as substrate or product for the enzyme reactions they par-
ticipate in. These low afﬁnities explain why from the point of view
of enzyme mechanisms these effects have notbeen considered
important. However, the concentrations of these energy metabo-
lites are often in the millimolar range and their variations may
therefore regulate cell function through these low afﬁnity pleiotro-
pic effects more than through their highly afﬁne substrate/product
effects. This offers an entirely new perspective on metabolic
regulation.
It should be noted that such pleiotropic effects may not be con-
ﬁned to the adenine nucleotides. Inorganic phosphate, nicotin-
amide adenine nucleotides and may other molecules may exert
similar effects. It is for this reason that we refrained from compar-
ing the new model predictions that incorporate the pleiotropic ef-
fects of the adenine nucleotides, to in vivo biochemistry. Table 5
does show relevant experimental in vivo data. It shows that the
pleiotropic effects are of the order of magnitude that could bridge
the existing discrepancies between in vivo and in vitro, but it also
suggests that the effects of the adenine nucleotides alone are not
enough to account for the discrepancy.
The adenine nucleotides may well affect many enzymes for
which they are neither substrate nor product by competing with
a different substrate or product with which they share a limitedamount of structural analogy. One may indeed expect ATP at high
concentrations to interfere slightly with the binding of any phos-
phorylated molecule to an enzyme. In this case we expect ATP
merely to increase the Michaelis–Menten constant by the factor
1 + [ATP]/KATP. Even though the afﬁnity for ATP of the binding site
might be low (e.g. 5 mM), since the physiological concentration of
ATP is often close to 5 mM it would well increase the KM for the
speciﬁc substrateby a factor of two and decrease the rate by almost
that same factor. This analysis shows that even a full century later,
the work of the Canadian biochemist avant la lettre Miss. Maud
Menten in the centre of Berlin [30], continues to enable us to
understand how biological function can be regulated through the
Michaelis–Menten constant too often named only after her col-
league Michaelis.
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